360head Stockiq
Global Intelligence Terminal
Loading live prices…
LIVE
--:--:--
AI-generated, informational and educational only. Not financial advice. Past performance does not indicate future results. Always do your own research.

Biontech SE (BNTX)

A research Signal Score of unusual activity and the signals behind it. Not advice, not a prediction, not yet backtested.

Biotechnology· DE· www.biontech.com
Trade BNTX on Webull →
0/100
Low signalSIGNAL SCORE
P(beat S&P 500 · next 20 sessions)42%

Also measured against its sector ETF (XBI).

Our last 30 days of resolved calls came true 18% of the time.See the track record →

Price
$85.60
1 day
+0.66%
1 week
-2.82%
Month to date
-3.55%
1 year
-23.87%
Market cap
$21.1B
Company fundamentals
EPS (TTM)
$-5.86
Debt / Equity
0.02
Current ratio
8.55
Operating margin
-75.4%
Net margin
-60.9%
Gross margin
79.1%
Return on equity
-8.0%
Revenue growth (YoY)
-10.7%

Figures reflect the most recent reported period. Margins, ROE and growth are percentages; Debt/Equity and Current ratio are ratios.

Example trade plan · illustrative risk framework
Entry zone
$84.32–$87.31
Stop-loss (exit)
$77.04 −10%
Target (exit)
$102.72 +20%

A generic 2:1 reward-to-risk example (about a 10% stop and 20% target). Illustrative and educational, not advice. Set your own levels for your risk tolerance.

Why it ranks: factor attribution

Score uses live volume/momentum/breakout signals today; insider buying, short interest, options flow and social velocity layer in as those sources come online. How it works →

Why it's moving: recent catalysts

🤖 Dominant catalyst is product/pipeline news, driven by clinical data updates and peer validation in the cancer vaccine space. Continuation probability is moderate, as positive headlines can sustain momentum but are subject to data-readout volatility. Informational only — not financial advice.

Any AI summary is an interpretation of public news, not advice or a price target.

BNTX Signal Score & analysis · 360head Stockiq